Williams v. AstraZeneca Pharmaceuticals LP et al
Carolyn Williams |
AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company and McKesson Corporation |
3:2016cv07152 |
December 14, 2016 |
US District Court for the Northern District of California |
San Francisco Office |
Sacramento |
Jon S. Tigar |
Personal Injury: Health Care |
28 U.S.C. ยง 1332 |
Defendant |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 103 TRANSFER ORDER by the United States Judicial Panel on Multidistrict Litigation TRANSFERRING CASE to the United States District Court for the Eastern District of Kentucky, MDL No. 2809. (tnS) (Filed on 2/13/2018) |
Filing 102 STIPULATION AND ORDER re (101 in 3:16-cv-07152-JST) STIPULATION WITH PROPOSED ORDER To Continue Case Management Conference Pursuant to N.D. Cal. Civ. L.R. 6-1 filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol -Myers Squibb Company. Case Management Statement due by 2/26/2018. Initial Case Management Conference set for 3/7/2018 at 2:00 PM in San Francisco, Courtroom 09, 19th Floor. Signed by Judge Jon S. Tigar on February 1, 2018. (wsn, COURT STAFF) (Filed on 2/1/2018) |
Filing 98 STIPULATION AND ORDER re (53 in 3:17-cv-00661-JST) STIPULATION WITH PROPOSED ORDER to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, Bristol-Myers Company, (97 in 3:16-cv-07152-JST) STIPULATION WITH PR OPOSED ORDER to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Squibb Company. Case Management Statement due by 12/11/2017. Further Case Management Conference set for 12/20/2017 at 2:00 PM in Courtroom 9, 19th Floor, San Francisco. Signed by Judge Jon S. Tigar on October 30, 2017. (wsn, COURT STAFF) (Filed on 10/30/2017) |
Filing 91 STIPULATION AND ORDER re (90 in 3:16-cv-07152-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesso n Corporation, Bristol-Myers Squibb Company, (47 in 3:17-cv-00661-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Company. Signed by Judge Jon S. Tigar on September 28, 2017. (wsn, COURT STAFF) (Filed on 9/28/2017) |
Filing 73 STIPULATION AND ORDER re 72 STIPULATION WITH PROPOSED ORDER TO CONTINUE DEADLINE TO SUBMIT PROPOSED ORDERS PURSUANT TO N.D. CAL. CIV. L.R. 6-1 filed by Carolyn Williams. Signed by Judge Jon S. Tigar on August 7, 2017. (wsn, COURT STAFF) (Filed on 8/7/2017) |
Filing 31 STIPULATION AND ORDER re 30 STIPULATION and Proposed Order selecting Private ADR by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company filed by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company. Signed by Judge Jon S. Tigar on March 22, 2017. (wsn, COURT STAFF) (Filed on 3/22/2017) |
Filing 27 Judicial Referral for Purpose of Determining Relationship of Cases re 17-cv-661.Signed by Magistrate Judge Donna M. Ryu on March 20, 2017. (dmrlc2, COURT STAFF) (Filed on 3/20/2017) |
Filing 21 Judicial Referral for Purpose of Determining Relationship of Cases re Okoye v. Bristol-Myers Squibb Co., Case No. 17-668. Signed by Judge Kandis A. Westmore on 2/13/2017. (kawlc2, COURT STAFF) (Filed on 2/13/2017) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.